Financhill
Back

AT&T, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
23

T
AT&T, Inc.

Last Price:
$24.24
Seasonality Move:
-0.82%
Sell
46

NKTR
Nektar Therapeutics

Last Price:
$44.03
Seasonality Move:
6.44%
Sell
23
AT&T, Inc. (T) is a Sell

Is AT&T, Inc. a Buy, Sell or Hold?

  • The current AT&T, Inc. [T] share price is $24.15. The Score for T is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • T is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $46.84. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

T Stock Price Chart

What is AT&T, Inc.'s stock price today?

  • The AT&T, Inc. share price today is $24.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and T is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $46.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

T Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.56 Buy
Relative Strength Index (14 RSI): 35.91 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.47 - 25.75) Sell
Bollinger Bands (100): (25.04 - 28.64) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.95 Sell
Relative Strength Index (14 RSI): 38.83 Sell
Chaikin Money Flow: 857593 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.69 - 61.39) Sell
Bollinger Bands (100): (34.99 - 62.73) Sell

T Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.3 Sell
20-day SMA: 25.02 Sell
50-day SMA: 25.23 Sell
200-day SMA: 27.17 Sell
8-day EMA: 12.83 Buy
20-day EMA: 6.29 Buy
50-day EMA: 2.74 Buy
200-day EMA: 0.72 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.29 Sell
20-day SMA: 55.51 Sell
50-day SMA: 57.37 Sell
200-day SMA: 31.53 Buy
8-day EMA: 49.58 Sell
20-day EMA: 53.48 Sell
50-day EMA: 54.29 Sell
200-day EMA: 38.34 Buy

AT&T, Inc. Earnings Growth & T Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $0.17 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.

AT&T, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):